Company Monitoring Page for Novartis

latest headlines for company on cafepharma

Novartis poaches a Harvard oncologist to head up immuno-oncology program
BioPharma Dive
Thu, 12/17/15 - 02:01 pm
Tags:
Novartis, Harvard, immuno-oncology
Novartis backs $176M microbiome biotech fund
Fierce Biotech
Mon, 12/14/15 - 10:14 pm
Tags:
Novartis, microbiome, Seventure Partners
Novartis: Lymphoma study shows CART on track for 2017 U.S. submission
Yahoo/Reuters
Mon, 12/7/15 - 03:08 pm
Tags:
Novartis, CAR-T, CTL019, non-Hodgkins lymphoma
Novartis: Study shows copycat works just as well as Amgen drug
Yahoo/Reuters
Mon, 12/7/15 - 12:10 pm
Tags:
Novartis, Amgen, Neulasta, Sandoz, generics, breast cancer
Novartis: Lymphoma study shows CART on track for 2017 U.S. submission
Yahoo/Reuters
Sun, 12/6/15 - 11:06 am
Tags:
Novartis, CAR-T, CTL019, non-Hodgkin's lymphoma
FDA OKs first generic for Gleevec leukemia pill
Yahoo/AP
Fri, 12/4/15 - 08:25 pm
Tags:
FDA, Gleevec, generics, Novartis, chronic myeloid leukemia, Sun Pharma
3 Leaders In Alzheimer's BACE Inhibition
Seeking Alpha
Wed, 12/2/15 - 11:05 am
Tags:
Alzheimer's disease, Amgen, AstraZeneca, BACE inhibitors, Eli Lilly, Merck, Novartis
Novartis' Cosentyx price sets the stage for psoriasis battle
Fierce Pharma Marketing
Mon, 11/30/15 - 10:28 am
Tags:
Novartis, Cosentyx, psoriasis, drug pricing
Valeant: Based On The Novartis Settlement, Philidor Legal Exposure Could Be $860MM
Seeking Alpha
Sun, 11/29/15 - 12:39 pm
Tags:
Valeant, Novartis, Philidor Rx
Novartis’s Cosentyx: Europe’s First IL-17A Inhibitor for Some Uses
Yahoo/Market Realist
Sun, 11/29/15 - 12:27 pm
Tags:
Novartis, Cosentyx, Europe, ankylosing spondylitis, psoriatic arthritis
Valeant, Glaxo, Novartis Skin Drug Prices Have Soared
Investors.com
Fri, 11/27/15 - 12:01 pm
Tags:
drug pricing, Valeant Pharmaceuticals, GSK, Novartis, dermatology
First flu vaccine with immune-boosting adjuvant approved for US market
Stat
Wed, 11/25/15 - 11:35 am
Tags:
flu vaccines, vaccines, immune-boosting adjuvants, Fluad, CSL, Novartis, Seqirus
FDA says Novartis plant in India backdated data and withheld info
Stat
Tue, 11/24/15 - 01:55 pm
Tags:
FDA, Novartis, India, drug manufacturing
Novartis snags new approvals for Cosentyx in Europe
Fierce Pharma
Tue, 11/24/15 - 09:49 am
Tags:
Novartis, Cosentyx, Europe, psoriasis
Novartis Admits To Valeant-like Pharmacy Scheme in $390 Million Settlement
Fortune
Fri, 11/20/15 - 06:33 pm
Tags:
Novartis, specialty pharmacies, Valeant Pharmaceuticals, kickbacks
Novartis biosimilar takes aim at Amgen drug Neulasta
Yahoo/Reuters
Wed, 11/18/15 - 09:30 am
Tags:
Novartis, Amgen, biosimilars, Neulasta, Sandoz
Roche joins Novartis' billion-dollar bet on Ophthotech's eye drug
Fierce Biotech
Tue, 11/17/15 - 05:53 pm
Tags:
Roche, Novartis, Ophthotech, pegpleranib
Novartis, Roche CEOs see performance-based future, but U.S. isn't ready yet
Fierce Biotech
Fri, 11/13/15 - 10:00 am
Tags:
Novartis, Roche, Pharma CEOs, Amgen, Repatha, Joe Jimenez, Severin Schwan
Why has uptake of Novartis' expected sales superstar Entresto been so slow?
BioPharma Dive
Wed, 11/4/15 - 07:58 am
Tags:
Novartis, Entresto, chronic heart failure
Novartis Is Struggling To Compete
Seeking Alpha
Mon, 11/2/15 - 06:05 pm
Tags:
Novartis

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.